News Highlights: Top Company News of the Day
December 01 2020 - 5:30AM
Dow Jones News
UniCredit's Mustier to Step Down as CEO Over Strategy Rift
Jean Pierre Mustier said it had become clear in recent months
that the core pillars of his strategy for the Italian bank "no
longer correspond to the board's current thinking."
Amazon Makes Mac Commitment, Opening Door to Apple Developers
Tech giants Amazon and Apple are joining forces to support the
growing number of companies developing apps and other software for
Apple devices.
Exxon Slashes Spending, Writes Down Assets
The struggling Texas oil giant is retreating from a plan to
increase spending to boost its oil and gas production by 2025 and
preparing to slash the book value of its assets by up to $20
billion.
Tesla to Enter S&P 500 at Full Weight in December
The electric-vehicle maker will be added to the broad
stock-market gauge before the start of trading Dec. 21, meaning
most index-tracking funds that follow the S&P 500 will engage
in a flurry of trading the Friday before.
Bankruptcy Judge Denies Lenders' Request to Block Sale of New York Sports Clubs Owner
Town Sports, operator of the New York Sports Clubs and Lucille
Roberts gym chains, got a green light to move forward with a plan
to wrap up a sale of its assets to its lenders and an entity
managed by investment banking firm Lepercq de Neuflize &
Co.
Credit Suisse Proposes Lloyds CEO as Chairman
Credit Suisse has proposed that Antonio Horta-Osorio, the
outgoing CEO of Lloyds Banking Group, becomes the Swiss bank's next
chairman.
SBM Offshore Faces Swiss Probe Over Legacy Bribery Allegations
Oil-services firm SBM Offshore is facing an investigation by the
Swiss government into bribery allegations that the company said it
has already paid hundreds of millions of dollars to resolve in
three other countries.
Zoom's Pandemic-Fueled Boom Continues
The videoconferencing company posted another quarter of record
sales and again lifted its outlook as remote working and distance
schooling drags on during the pandemic.
Novavax Delays Covid-19 Vaccine Study Over Manufacturing Issues
Novavax has delayed starting a large, decisive clinical trial of
its Covid-19 vaccine in the U.S. and Mexico to sometime in the
coming weeks due to manufacturing issues, versus an earlier plan to
start by the end of November.
Moderna Asks FDA to Authorize Vaccine
The drugmaker is seeking approval for its Covid-19 vaccine after
it was shown to be 94.1% effective, keeping the shot on track for
use in the U.S. by year's end, alongside Pfizer and BioNTech.
(END) Dow Jones Newswires
December 01, 2020 05:15 ET (10:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.